SCHEMBL25822101

SCHEMBL25822101

Cc1ncnn2c([C@@H]3O[C@](F)(CI)[C@@H](OC(=O)C(C)C)[C@H]3OC(=O)C(C)C)ccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25822097 0.91 — —
SCHEMBL25822107 0.81 POLRMT (0.38) —
SCHEMBL25822105 0.77 POLRMT (0.36) —
SCHEMBL26230756 0.73 POLRMT (0.39) —
SCHEMBL23803220 0.71 POLRMT (0.36) —
SCHEMBL23803201 0.71 POLRMT (0.37) —
SCHEMBL25385857 0.71 POLRMT (0.37) —
SCHEMBL26229754 0.71 — —
SCHEMBL27439151 0.70 POLRMT (0.31) —
SCHEMBL25387899 0.69 TMPRSS2 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219993-A1 ANTIVIRAL APPLICATION OF NUCLEOSIDE ANALOG OR COMBINATION FORMULATION CONTAINING NUCLEOSIDE ANALOG VIGONVITA LIFE SCIENCES CO., LTD. (CN) 2023-07-13 — — US disclosed
Send feedback